Envoy Medical, Inc.
COCH
$0.84
$0.045.07%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.92% | -13.85% | -8.23% | 22.52% | -51.00% |
| Total Depreciation and Amortization | -10.59% | 39.34% | 27.08% | -2.04% | 16.67% |
| Total Amortization of Deferred Charges | -0.41% | -0.40% | -76.41% | 287.78% | 0.37% |
| Total Other Non-Cash Items | 29.93% | 1,811.63% | -70.34% | -91.84% | 243.62% |
| Change in Net Operating Assets | 889.61% | -91.65% | 191.29% | -181.45% | 443.86% |
| Cash from Operations | 2.89% | -19.73% | 15.11% | -67.29% | 43.54% |
| Capital Expenditure | 100.00% | 83.33% | -101.12% | 186.83% | 22.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 83.33% | -101.12% | 186.83% | 22.15% |
| Total Debt Issued | -100.00% | 0.00% | 0.00% | -33.33% | 200.00% |
| Total Debt Repaid | -13.14% | -1.29% | 74.56% | -397.83% | 29.77% |
| Issuance of Common Stock | 864.41% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 100.00% | 49.96% | -97.56% | 66.50% | -- |
| Other Financing Activities | -- | -- | -- | 318.20% | -- |
| Cash from Financing | -41.39% | 24.87% | -27.68% | -16.95% | 164.39% |
| Foreign Exchange rate Adjustments | 50.00% | -133.33% | 400.00% | -100.00% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6,824.00% | 85.38% | -116.15% | -60.46% | 183.71% |